Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$32.1258 0.9258 | 2.97%
08/24/16 - 12:31 PM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -287.80M 912.20M -863.67M -116.03M
Operating Gains/Losses 25.40M -123.90M 69.37M 8.46M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -625.90M -572.40M -261.38M -219.43M
(Increase) Decrease in Inventories -276.00M -174.30M -122.70M -80.30M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 170.30M 188.60M -76.55M -29.07M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 20.70M
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 519.20M 285.40M 625.16M 314.40M
Net Cash From Continuing Operations 2.20B 2.29B 1.04B 656.58M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 2.20B 2.29B 1.04B 656.58M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 92.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 66.70M 53.20M 0.00 0.00
Purchases of Property, Plant & Equipment -303.30M -470.60M -184.96M -181.13M
Acquisitions -15.44B 389.70M -5.25B -3.49B
Purchases of Short-Term Investments -49.30M -72.00M 0.00 -7.20M
Other Cash from Investing Activities -31.50M 0.00 41.09M -8.87M
Cash Provided by Financing Activities
Net Cash From Investing Activities -15.58B -99.70M -5.38B -2.97B
Issuance of Debt 17.82B 1.65B 8.47B 6.04B
Cash Used for Financing Activities
Issuance of Capital Stock 30.20M 17.20M 10.02M 23.03M
Repayment of Long-Term Debt -5.19B -3.92B -6.40B -2.57B
Repurchase of Capital Stock -72.40M 0.00 -55.63M -280.72M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.08B -196.50M 2.01B -155.61M
Net Cash From Financing Activities 13.68B -2.44B 4.03B 3.06B
Effect of Exchange Rate Changes -30.10M -29.00M -5.07M 3.75M
Net Change in Cash & Cash Equivalents 274.70M -277.70M -315.75M 751.98M

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter